Compile Data Set for Download or QSAR
maximum 50k data
Found 57 Enz. Inhib. hit(s) with all data for entry = 5897
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99192(US8501708, 12)
Affinity DataKi:  1.72nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99205(US8501708, 29)
Affinity DataKi:  2.28nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99204(US8501708, 28)
Affinity DataKi:  2.65nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99197(US8501708, 17)
Affinity DataKi:  2.79nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99193(US8501708, 13)
Affinity DataKi:  2.97nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99206(US8501708, 30)
Affinity DataKi:  3.53nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99199(US8501708, 19)
Affinity DataKi:  3.61nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99202(US8501708, 22)
Affinity DataKi:  3.68nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99210(US8501708, 34)
Affinity DataKi:  4.86nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  5.59nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99208(US8501708, 32)
Affinity DataKi:  6.06nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  6.08nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99203(US8501708, 23)
Affinity DataKi:  12.3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99198(US8501708, 18)
Affinity DataKi:  12.6nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99200(US8501708, 20)
Affinity DataKi:  14.4nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99201(US8501708, 21)
Affinity DataKi:  28.8nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  29nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  53.1nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99205(US8501708, 29)
Affinity DataKi:  422nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99192(US8501708, 12)
Affinity DataKi:  476nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  551nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99193(US8501708, 13)
Affinity DataKi:  820nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99202(US8501708, 22)
Affinity DataKi:  1.29E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99201(US8501708, 21)
Affinity DataKi:  1.29E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99197(US8501708, 17)
Affinity DataKi:  1.35E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Oryctolagus cuniculus (Rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99196(US8501708, 16)
Affinity DataKi:  1.36E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99198(US8501708, 18)
Affinity DataKi:  1.57E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99199(US8501708, 19)
Affinity DataKi:  1.63E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99200(US8501708, 20)
Affinity DataKi:  1.87E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99210(US8501708, 34)
Affinity DataKi:  2.27E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99203(US8501708, 23)
Affinity DataKi:  2.30E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99193(US8501708, 13)
Affinity DataKi:  2.53E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  2.55E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99206(US8501708, 30)
Affinity DataKi:  2.55E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99192(US8501708, 12)
Affinity DataKi:  2.62E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99204(US8501708, 28)
Affinity DataKi:  2.62E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  2.77E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99202(US8501708, 22)
Affinity DataKi:  2.98E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99204(US8501708, 28)
Affinity DataKi:  3.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99210(US8501708, 34)
Affinity DataKi:  3.37E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99208(US8501708, 32)
Affinity DataKi:  3.38E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.71E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99194(US8501708, 14 | US8501708, 15)
Affinity DataKi:  3.74E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.78E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99206(US8501708, 30)
Affinity DataKi:  4.04E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99205(US8501708, 29)
Affinity DataKi:  5.10E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99197(US8501708, 17)
Affinity DataKi:  5.32E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99199(US8501708, 19)
Affinity DataKi:  5.54E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99201(US8501708, 21)
Affinity DataKi:  6.83E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2(Oryctolagus cuniculus (rabbit))
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99198(US8501708, 18)
Affinity DataKi:  7.33E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: